US Government Orders Additional Smallpox-Monkeypox Vaccines

In COVID-19, Latest News by Precision Vaccinations

The U.S. Biomedical Advanced Research and Development Authority (BARDA) has exercised the final $12 million option for JYNNEOS, an innovative combination of Smallpox and Monkeypox vaccine.
JYNNEOS is the only U.S. Food and Drug Administration-approved non-replicating smallpox and monkeypox vaccine for preventing disease in adults 18 years of age and older.

Read More